These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1304 related items for PubMed ID: 25159156

  • 1. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M, Lin Q, Nishikawa K, Ohtsuji N, Okazaki H, Tsurui H, Amano H, Shirai T, Nishimoto N, Nishimura H, Hirose S.
    Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
    [Abstract] [Full Text] [Related]

  • 2. TNFα but not IL-17 is critical in the pathogenesis of rheumatoid arthritis spontaneously occurring in a unique FcγRIIB-deficient mouse model.
    Okazaki H, Lin Q, Nishikawa K, Ohtsuji N, Tsurui H, Ohtsuji M, Amano H, Tada N, Sudo K, Nishimura H, Shirai T, Hirose S.
    Mod Rheumatol; 2014 Nov; 24(6):931-8. PubMed ID: 24593165
    [Abstract] [Full Text] [Related]

  • 3. Anti-CD11b antibody treatment suppresses the osteoclast generation, inflammatory cell infiltration, and autoantibody production in arthritis-prone FcγRIIB-deficient mice.
    Ohtsuji M, Lin Q, Okazaki H, Takahashi K, Amano H, Yagita H, Nishimura H, Hirose S.
    Arthritis Res Ther; 2018 Feb 08; 20(1):25. PubMed ID: 29422084
    [Abstract] [Full Text] [Related]

  • 4. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
    Liu C, Yang Y, Sun D, Wang C, Wang H, Jia S, Liu L, Lin N.
    Rejuvenation Res; 2015 Dec 08; 18(6):528-42. PubMed ID: 26418168
    [Abstract] [Full Text] [Related]

  • 5. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G.
    Arthritis Rheum; 2004 Jan 08; 50(1):277-90. PubMed ID: 14730626
    [Abstract] [Full Text] [Related]

  • 6. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
    Naidu VG, Dinesh Babu KR, Thwin MM, Satish RL, Kumar PV, Gopalakrishnakone P.
    Chem Biol Interact; 2013 Apr 25; 203(2):467-79. PubMed ID: 23333834
    [Abstract] [Full Text] [Related]

  • 7. Bone destruction in arthritis.
    Gravallese EM.
    Ann Rheum Dis; 2002 Nov 25; 61 Suppl 2(Suppl 2):ii84-6. PubMed ID: 12379632
    [Abstract] [Full Text] [Related]

  • 8. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
    van Lent PL, Grevers L, Lubberts E, de Vries TJ, Nabbe KC, Verbeek S, Oppers B, Sloetjes A, Blom AB, van den Berg WB.
    Arthritis Rheum; 2006 Dec 25; 54(12):3868-77. PubMed ID: 17133594
    [Abstract] [Full Text] [Related]

  • 9. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T, Miyamoto T, Yoshida H, Asakawa M, Kawasumi M, Kobayashi T, Morioka H, Chiba K, Toyama Y, Yoshimura A.
    Int Immunol; 2011 Nov 25; 23(11):701-12. PubMed ID: 21937456
    [Abstract] [Full Text] [Related]

  • 10. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM.
    Rheumatology (Oxford); 2006 Sep 25; 45(9):1068-76. PubMed ID: 16490750
    [Abstract] [Full Text] [Related]

  • 11. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
    Chen Y, Wang X, Yang M, Ruan W, Wei W, Gu D, Wang J, Guo X, Guo L, Yuan Y.
    Med Sci Monit; 2018 Jul 30; 24():5292-5300. PubMed ID: 30059491
    [Abstract] [Full Text] [Related]

  • 12. Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.
    Ainola M, Mandelin J, Liljeström M, Konttinen YT, Salo J.
    Clin Exp Rheumatol; 2008 Jul 30; 26(2):240-6. PubMed ID: 18565244
    [Abstract] [Full Text] [Related]

  • 13. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
    Arthritis Res; 1999 Jul 30; 1(1):81-91. PubMed ID: 11056663
    [Abstract] [Full Text] [Related]

  • 14. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB.
    Arthritis Rheum; 2004 Feb 30; 50(2):650-9. PubMed ID: 14872510
    [Abstract] [Full Text] [Related]

  • 15. A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines.
    Sun Y, Yao Y, Ding CZ.
    Int Immunopharmacol; 2014 Jan 30; 18(1):135-41. PubMed ID: 24287449
    [Abstract] [Full Text] [Related]

  • 16. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
    Shen Y, Jiang T, Wang R, He S, Guo M, Zuo J, He D.
    BMC Complement Altern Med; 2015 Mar 24; 15():77. PubMed ID: 25887296
    [Abstract] [Full Text] [Related]

  • 17. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B, Cantaert T, Noordenbos T, Tak PP, Baeten D.
    Arthritis Rheum; 2008 Mar 24; 58(3):718-29. PubMed ID: 18311801
    [Abstract] [Full Text] [Related]

  • 18. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
    Tunyogi-Csapo M, Kis-Toth K, Radacs M, Farkas B, Jacobs JJ, Finnegan A, Mikecz K, Glant TT.
    Arthritis Rheum; 2008 Aug 24; 58(8):2397-408. PubMed ID: 18668542
    [Abstract] [Full Text] [Related]

  • 19. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.
    Geusens PP, Landewé RB, Garnero P, Chen D, Dunstan CR, Lems WF, Stinissen P, van der Heijde DM, van der Linden S, Boers M.
    Arthritis Rheum; 2006 Jun 24; 54(6):1772-7. PubMed ID: 16736519
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK, Cho ML, Park MK, Oh HJ, Park JS, Her YM, Lee SY, Youn J, Ju JH, Park KS, Kim SI, Kim HY, Park SH.
    Arthritis Rheum; 2012 Mar 24; 64(3):740-51. PubMed ID: 21968544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.